DCLK1 and cancer: Given that both hypoxia and PLOD2 play critical roles in α-promoter-preferred DCLK1 activation, and that PLOD2 is a known a hypoxia-responsive gene in multiple cancers [38, 48, 51], we hypothesized that PLOD2 mediates hypoxia-induced activation of DCLK1-L.